1. Home
  2. MP vs ICLR Comparison

MP vs ICLR Comparison

Compare MP & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MP Materials Corp.

MP

MP Materials Corp.

HOLD

Current Price

$72.90

Market Cap

10.3B

ML Signal

HOLD

Logo ICON plc

ICLR

ICON plc

HOLD

Current Price

$124.21

Market Cap

9.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MP
ICLR
Founded
2017
1990
Country
United States
Ireland
Employees
N/A
41900
Industry
Metal Mining
Biotechnology: Commercial Physical & Biological Resarch
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3B
9.3B
IPO Year
2020
2001

Fundamental Metrics

Financial Performance
Metric
MP
ICLR
Price
$72.90
$124.21
Analyst Decision
Strong Buy
Buy
Analyst Count
13
13
Target Price
$75.25
$178.62
AVG Volume (30 Days)
5.1M
1.3M
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
12.28
N/A
EPS
N/A
N/A
Revenue
$331,952,000.00
N/A
Revenue This Year
$100.51
N/A
Revenue Next Year
$60.41
N/A
P/E Ratio
N/A
$12.91
Revenue Growth
147.15
N/A
52 Week Low
$18.64
$66.57
52 Week High
$100.25
$211.00

Technical Indicators

Market Signals
Indicator
MP
ICLR
Relative Strength Index (RSI) 67.49 62.27
Support Level $59.06 $99.11
Resistance Level $74.18 $193.87
Average True Range (ATR) 4.24 5.98
MACD 0.76 1.34
Stochastic Oscillator 98.01 95.92

Price Performance

Historical Comparison
MP
ICLR

About MP MP Materials Corp.

MP Materials Corp is the producer of rare earth materials in the Western Hemisphere. The company owns and operates the Mountain Pass Rare Earth Mine and Processing Facility, the only rare earth mining and processing site of scale in North America. The company is also developing a rare earth metal, alloy, and magnet manufacturing facility in Fort Worth, Texas. The company's operations are organized into two reportable segments: Materials and Magnetics.

About ICLR ICON plc

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Share on Social Networks: